VMDViemed Healthcare, Inc.
Price
+37%1YEnd-of-day closes, not the intraday tick.
More going right than wrong
Quality strong, nothing alarming, price roughly fair, growth steady, the market undecided.
Charts
As reported to the SEC, without any scoring.
Viemed Healthcare, Inc. (VMD) reported revenue of $78M in Q2 2026 (quarter ended Jun 30, 2026), up 24% from the same quarter a year earlier. That came with a gross margin of 58% and net income of $2.8M (3.5% of revenue). For the full year FY2025, revenue was $270M (+21% year on year) and net income $15M. The next results filing is expected around Nov 4, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Jun 4, 2026Viemed Healthcare, Inc. (the “Company”) held its Annual General and Special Meeting of Shareholders (the “Meeting”) on June 4, 2026.Director or officer change · Form 8-K
- Mar 4, 2026On March 4, 2026, the Company's Board of Directors authorized and approved a share repurchase program on Nasdaq.Earnings release · Form 8-K
- Nov 7, 2025On November 7, 2025, Viemed, Inc. (the “Borrower”), and certain subsidiaries of the Borrower, as guarantors (the "Guarantors"), all of which are wholly-owned subsidiaries of Viemed Healthcare, Inc. (the "Company"), entered into a Third Amendment (the "Third Amendment") to the Credit Agreement dated as of November 29 …Material agreement entered · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.